How many institutions held IKT - Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value in Q3 2026?

2 institutional investors reported IKT - Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value for Q3 2026. Use the holders table for investor-level position and value details.

Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Q: What does CUSIP 45719W205 represent in this 13F holders report?

CUSIP 45719W205 is the security identifier for IKT - Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 45719W205

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, $0.001 par value
Total 13F shares: 1,581
Total 13F value: $3,249
Share change: +1,211
SEC-reported price per share: $2.06
Number of holders: 2
Value change: +$2,489
Number of buys: 2
Shares outstanding: 135,127,605

Security key

45719W205

Report period

Q3 2026

Institutions

Top holders

IKT full security history Ownership snapshot Full 13F holder table Previous quarter: Q2 2026 Inhibikase Therapeutics, Inc. SEC filings Inhibikase Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 45719W205

Previous quarter: Q2 2026

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of IKT - Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

30 Jul 2026

13D/G 3/4/5 13F Lead comparable stake: 9.9% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 9.9%

Commodore Capital LP 9.9%

ADAR1 Capital Management, LLC 9.9%

Fairmount Funds Management LLC 9.9%

Sands Capital Life Sciences Pulse... 9.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	9.9%	$29,894,148 14,653,994 shares	-$21,105,852	29 Jul 2026
Commodore Capital LP	13D/G 13F Company 13D/G 13F	9.9%	$25,439,441 14,054,940 shares	$0	31 Mar 2026
ADAR1 Capital Management, LLC	13D/G 13F Company 13D/G 13F	9.9%	$25,086,651 13,860,028 shares	+$2,113,430	31 Mar 2026
Fairmount Funds Management LLC	13D/G 13F Company 13D/G 13F	9.9%	$24,922,202 12,461,101 shares	+$10,885,052	31 Dec 2025
Sands Capital Life Sciences Pulse Fund II, L.P.	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	9.3%	$26,558,689 13,018,965 shares	$0	30 Jun 2026
PERCEPTIVE ADVISORS LLC	13D/G 13D/G	6.9%	$21,054,585 10,320,875 shares	-$4,722,600	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,581

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

105

Q3 2026 holders

Holder diff

-103

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend